Can I Get an Allergy Shot? A Personal Candidacy Self-Assessment

Allergy shots are indicated when allergic rhinitis is classified as moderate-to-severe by the ARIA (Allergic Rhinitis and its Impact on Asthma) severity framework. Specifically, your symptoms are severe enough if they: disrupt your sleep (waking up with congestion, sneezing, or itching), impair daily activities you would otherwise do without difficulty, affect your work or school performance, or cause you significant bother even if you can still function. If any one of these four domains is meaningfully impacted, you meet the severity threshold. A symptom diary tracking your daily allergy impact across these domains over a full season is a useful tool for documenting severity objectively. Bring this diary to your allergist consultation — it provides far more useful information than a verbal 'my allergies are bad' summary. Mild allergies well-controlled with minimal medication typically do not meet the threshold for immunotherapy.

Before getting allergy shots, you need documented IgE-mediated sensitization through either skin prick testing (SPT) or serum-specific IgE blood testing (such as ImmunoCAP). Skin prick testing is the most commonly performed in-office diagnostic tool: small amounts of common allergen extracts are applied to the skin surface and the skin is lanced to allow penetration, then measured for wheal-and-flare reactions at 15-20 minutes. Serum-specific IgE testing uses a blood draw to measure IgE antibodies to specific allergens in the laboratory. Both methods are acceptable for immunotherapy extract design, and allergists often use both. The testing results must correlate with your clinical symptoms — sensitization alone without relevant symptoms does not establish an immunotherapy indication. Your allergist will use the testing data to design your personalized extract formula, so comprehensive testing across the allergen categories relevant to your symptom pattern is important before committing to a multi-year injection course.

You can self-screen for most common absolute contraindications before your allergist consultation. Review your current medication list for: any beta-blockers (metoprolol, atenolol, propranolol, carvedilol, labetalol, nadolol, and others — check with your pharmacist if uncertain), which are an absolute contraindication. Assess your current asthma status: if you have asthma that is active, with current wheezing or recent ER visits, your asthma must be better controlled before starting shots. Consider pregnancy: if you are currently pregnant, allergy shot initiation is contraindicated. Review your medical history for immunodeficiency disorders or active malignancy. If none of these apply, you likely have no absolute contraindications — but your allergist will conduct a formal contraindication screening at your consultation visit. You should bring your complete medication list to the allergist appointment, as some prescription medications you may not associate with allergy shots can affect candidacy.

The standard pharmacotherapy failure criterion for immunotherapy candidacy is: at least one full allergy season during which you consistently used a second-generation antihistamine (cetirizine, loratadine, or fexofenadine) PLUS an intranasal corticosteroid (fluticasone, budesonide, or mometasone) daily throughout the season, and your symptoms remained moderate-to-severe despite this regimen. Key word: consistently. Taking antihistamines only when symptoms are already bad, or stopping your nasal spray after a week, does not count as an adequate medication trial. If you have tried only antihistamines without nasal steroids (or vice versa), or have used them sporadically, your allergist may recommend completing a proper optimized pharmacotherapy trial before immunotherapy. Some clinical situations — severe quality of life impairment, development of asthmatic symptoms, patient preference for disease modification — may justify earlier immunotherapy referral with documentation by the treating physician.

Your first allergist appointment typically involves four components: a detailed medical history review, allergy testing, a treatment discussion, and — if you are a candidate — an extract prescription order. The history covers your symptom pattern (seasonal vs year-round, which symptoms, how long, what triggers), prior medications and response, relevant medical history and medications, and your goals and lifestyle considerations. Allergy testing (skin prick testing or blood testing) documents your specific sensitizations. The treatment discussion covers your candidacy assessment, the extract design, the protocol timeline (build-up and maintenance), and costs and insurance coverage. If you decide to proceed, your allergist orders your customized extract from a specialty compounding facility — this typically takes 2-4 weeks to arrive before your first injection visit. Bring your complete medication list, any prior allergy test results, a symptom diary if you have one, and your insurance card.

Full-time work is a common practical challenge for allergy shot candidates, and there are several strategies to make the weekly build-up phase manageable. Most allergy practices offer early morning, late afternoon, and Saturday appointment slots specifically to accommodate working patients. Before-work appointments (if your allergist opens early enough) allow injection plus 30-minute observation before your workday starts. After-work appointments work if your allergist has evening hours. Some patients take a regular weekly half-day of PTO specifically for the 6-month build-up phase, then transition to the much easier monthly maintenance schedule. Cluster immunotherapy protocols can compress the build-up phase to 4-8 weeks with multiple injections per visit — fewer total visits but more intensive ones. Ask your allergist about cluster protocols specifically if your work schedule makes conventional weekly visits very difficult. Once you are on monthly maintenance, the schedule burden drops dramatically.

The decision between immunotherapy and long-term medication use involves weighing treatment burden, cost, and long-term goals. Medications (antihistamines, nasal steroids) are convenient, low-commitment, and immediately effective when taken — but they require daily use indefinitely and provide no benefit after stopping. Immunotherapy requires a 3-5 year commitment with frequent office visits — but may provide years of lasting benefit after completing the course and has disease-modification potential that medications cannot offer. Cost-effectiveness analysis by Hankin et al. (JACI, 2013) showed immunotherapy becomes cost-effective compared to ongoing pharmacotherapy at approximately 3 years into the treatment course, assuming cost savings continue after treatment ends. The decision is most compelling for: patients with moderate-to-severe symptoms despite medications, children (disease modification window), patients who dislike daily medication use, and patients with allergic asthma in addition to rhinitis.